Acrospire Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,169
Closed -$117K 1012
2017
Q2
$117K Sell
3,169
-295
-9% -$9.63K 0.11% 164
2017
Q1
$97K Buy
3,464
+1,964
+131% +$55.4K 0.08% 337
2016
Q4
$44K Buy
+1,500
New +$40.9K 0.02% 1473
2016
Q3
Sell
-1,300
Closed -$24K 2106
2016
Q2
$24K Sell
1,300
-900
-41% -$18.8K 0.02% 1469
2016
Q1
$59K Buy
+2,200
New +$63.1K 0.04% 780

Other funds holding PAHC

Acrospire Investment Management's PAHC Position: Q3 2017 in Review

Acrospire Investment Management sold out of Phibro Animal Health (PAHC) in Q3 2017, closing a stake of 3,169 shares — an estimated $117K sold.

Acrospire Investment Management first reported a position in PAHC in Q1 2016 and held it in 5 quarters. The position peaked at $117K in Q2 2017. 164 funds tracked by Wall St. Rank hold PAHC as of Q3 2017.

  • Acrospire Investment Management reported no remaining Phibro Animal Health position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 3,169 Phibro Animal Health shares in Q3 2017, an estimated $117K.
  • Acrospire Investment Management first reported a position in Phibro Animal Health in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Phibro Animal Health position peaked at $117K in Q2 2017.
  • 164 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.